Evaluation of Cytokine-induced Killer (CIK) Cells as Therapy or Adjuvant Treatment for Advanced HCC
Clinical trial NCT02568748 · UNKNOWN
Trial details
- NCT number
- NCT02568748
- Sponsor
- Sherief Abd-Elsalam
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-01
- Primary completion
- 2019-06-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.